Scienture Expands Arbli Coverage by About 12.5 Million Lives, Stock Climbs
Scienture Holdings Inc. (NASDAQ: SCNX) saw its shares rise 5.8% after the company announced it secured additional payor coverage representing roughly 12.5 million incremental covered lives for Arbli, its losartan potassium oral suspension. The coverage expansion includes Medicare Part D supplement plans and other commercial and government-sponsored…